3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Cisplatin
20
Docetaxel
19
Capecitabine
19
Oxaliplatin
14
Drug Therapy
14
Cyclophosphamide
14
Paclitaxel
13
Fluorouracil
12
Radiotherapy
11
apatinib
9
Gemcitabine
9
Doxorubicin
9
Decitabine
9
Methotrexate
8
Epirubicin
8
Carboplatin
8
sintilimab
6
Etoposide
6
camrelizumab
5
anlotinib
5
XELOX
5
Sorafenib
5
Radiation
5
Pemetrexed
5
Neoadjuvant Therapy
5
Leucovorin
5
Idarubicin
5
Dexamethasone
5
Cytarabine
5
Busulfan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Unknown
×
vosaroxin
×
Clear all
NCT02272478
2020-01-23
AML18
Cardiff University
Phase 2/3
Unknown
1,600 enrolled